Search Results

CEO’s review of 2021

CEOs review Jonathan Muir, Chief Executive Officer Performance highlights 2021 was a very strong year and left us well prepared for the new future that we are faced with. I would like to echo Mervyn’s comments on the abhorrent war and the sincere thanks to our colleagues – over 100,000 people at L1 and in […]

Chair’s review 2021

Chair’s review Lord Davies of Abersoch Emerging from a challenging period I want to start with an issue that sits outside this report. Russia is waging an unjustifiable and abhorrent war against Ukraine that is causing untold damage to the lives of millions. The strong response by the West has implications for L1 that we […]

Franz Humer appointed to the Board of LetterOne

Franz Humer appointed to the Board of LetterOne Franz Humer, experienced Non Executive and Chair joins the Board of LetterOne Mr Humer is former Chairman of Diageo and former CEO of Roche Mr Humer brings decades of managerial and Board experience to LetterOne Commenting on his appointment, Franz Humer said: “LetterOne is a major employer […]

Changes to L1 board and major charity initiative

As this terrible war continues to ravage Ukraine and its people, the board of LetterOne is taking all action necessary to protect the 120,000 jobs LetterOne’s investments support and to help people in desperate need in Ukraine. Mikhail Fridman and Petr Aven’s shareholdings are frozen indefinitely and they cannot receive dividends or any other financial […]

Statement by Mervyn Davies, Chairman and Jonathan Muir, Chief Executive LetterOne

Statement by Mervyn Davies, Chairman and Jonathan Muir, Chief Executive LetterOne Following the imposition of EU Sanctions, Mikhail Fridman and Petr Aven have stepped down from the LetterOne board. As a result, they will no longer have any involvement with or influence over the business or its investments. They will not receive dividends, communications or […]

Mikhail Fridman’s letter on war in Ukraine

  As reported widely in the media, on Friday Mikhail wrote to all LetterOne staff expressing his deep sadness at the war in Ukraine and his desire for the bloodshed to stop. This is a copy of the note. Dear Colleagues, I wanted to write to you after what has been an incredibly difficult few […]

L1 Energy invests in H2scan

L1 Energy has invested $50m in H2scan, a world leader in providing hydrogen sensors for electricity utilities and industrial markets. Our investment will underpin the company’s rapid expansion. H2scan’s innovative hydrogen sensing products, made in the USA, are key to the reliability of electricity transformers as well as serving a widespread of applications in the […]

LetterOne commits £1million over two years to support the Centre for Entrepreneurs

LetterOne commits £1million over two years to support the Centre for Entrepreneurs Funding supports new research efforts and fosters new generation of founders LetterOne, the long-term investment group, is committing £1million over two years to support the Centre for Entrepreneurs (CFE), the UK’s leading entrepreneurship foundation which aims to make Britain more entrepreneurial. The funding […]

LetterOne invests in recycling pioneer Plastic Energy

LetterOne invests  in recycling pioneer Plastic Energy LetterOne, an entrepreneurial, long-term investor in sectors that deliver financial and social value, is investing to accelerate the growth of Plastic Energy, the award-winning pioneer in the chemical recycling of plastic waste. Headquartered in the UK,  Plastic Energy’s vision is to create a circular economy in plastic by […]

L1 Health and Blantyre Capital acquire Remedica and Sun Wave Pharma

L1 Health has jointly acquired two European pharmaceutical companies in partnership with investment firm Blantyre Capital. On October 4th, shareholders in Johannesburg-listed Ascendis Health approved a restructuring plan under which senior debt holders L1 Health and Blantyre Capital exchanged outstanding debt for assets including Remedica and Sun Wave Pharma. The transaction closed on October 21st. […]